The role of allogeneic-cell transplantation in leukemia

New England Journal of Medicine

Volumn 363, Issue 22, 2010, Pages 2158-2159

  Kersey, John H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; MYCOPHENOLIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; EDITORIAL; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK REDUCTION;

EID: 78649414669     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1010818     Document Type: Editorial

References (10)

1. Atkinson K, Champlin R, Ritz J, Fibbe WE, Ljungman P, Brenner MK. Clinical bone marrow and blood stem cell transplantation. 3rd ed. New York: Cambridge University Press, 2004.
2. Appelbaum FR, Forman SJ, Negrin RS, Blume KG. Thomas' hematopoietic cell transplantation. 4th ed. Malden, MA: Wiley-Blackwell Publishing, 2009.
3. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010;363:2091-101.
4. Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006;144:407-14.
5. Friedrichs B, Tichelli A, Bacigalupo A, et al. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. Lancet Oncol 2010;11:331-8.
6. Baker KS, Ness KK, Weisdorf D, et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia 2010 September 23 (Epub ahead of print).
7. Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009;114:4293-9.
8. Miller JS, Warren EH, van den Brink MR, et al. NCI First International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. Biol Blood Marrow Transplant 2010;16:565-86.
9. Gupta V, Tallman MS, He W, et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood 2010;116:1839-48.
10. McClune BL, Weisdorf DJ, Pedersen TL, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol 2010;28:1878-87.